The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2016

Filed:

Jan. 07, 2015
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Samir Mitragotri, Santa Barbara, CA (US);

Sumit Paliwal, Goleta, CA (US);

Makoto Ogura, Ryugasaki, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 10/00 (2006.01); C12M 1/42 (2006.01); C12M 1/00 (2006.01); A61B 10/02 (2006.01); A61M 37/00 (2006.01); G01N 1/28 (2006.01); G01N 1/40 (2006.01); A61B 10/04 (2006.01); A61B 18/20 (2006.01); A61B 17/00 (2006.01); A61B 17/32 (2006.01); A61B 18/00 (2006.01); A61N 7/02 (2006.01); G01N 1/44 (2006.01);
U.S. Cl.
CPC ...
C12M 35/08 (2013.01); A61B 10/02 (2013.01); A61M 37/0015 (2013.01); C12M 23/28 (2013.01); C12M 31/00 (2013.01); G01N 1/286 (2013.01); G01N 1/4044 (2013.01); A61B 10/0045 (2013.01); A61B 10/0096 (2013.01); A61B 10/0283 (2013.01); A61B 10/04 (2013.01); A61B 18/20 (2013.01); A61B 2017/00761 (2013.01); A61B 2017/320004 (2013.01); A61B 2018/00452 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0046 (2013.01); A61N 7/02 (2013.01); G01N 1/44 (2013.01); Y10T 436/2575 (2015.01);
Abstract

Described are devices, methods and systems for applying energy and/or a liquefaction promoting medium to a tissue of interest to generate a liquefied tissue sample. The liquefied tissue sample may be removed from the tissue of interest. Also described are compositions of the liquefaction promoting medium that may facilitate liquefaction, preserve liquefied tissue constituents, and/or enable delivery of molecules into tissues. The sample may include tissue constituents to provide for rapid tissue sampling, tissue decontamination as well as detection of analytes. One or more drugs may be delivered through or into the tissue of interest. Determination of tissue composition in the liquefied tissue sample can be used, e.g., for diagnosis or prognosis of diseases, evaluating bioavailability of therapeutic agents in different tissues following administration, forensic detection of drugs-of-abuse, evaluating changes in the tissue microenvironment following exposure to a harmful agent, and the like.


Find Patent Forward Citations

Loading…